Report 1
Date : August 12, 2007 Page 1 of 1
Treatment –expected Adeverse Events in Descreding Order of Frequency
_____________________________________________________________________________
expected Adeverse Event Term Col – 5 mg Col – 10 mg Col
(N=120) (N=120) (N=99)
_____________________________________________________________________________
Number of Patients With
Expected Adverse Event (s) 80(66.6 %) 45(37.5%) 20(20.0%)
145(60.0%)
GROUP100 40(33.3%) 27(22.5%) 10(10.10%)
GROUP200 26(21.6%) 13(10.8%) 7(7.7%)
GROUP300 14(11.6%) 5(4.16%) 2(2.0%)
_____________________________________________________________________________
To Caluculate Percentage NO of adevent sub / Total No of Project
Report 2
Date : August 12, 2007 Page 2 of 2
Treatment –expected Adverse Event list in Descending Order of Frequency
_____________________________________________________________________________
expected Adverse Event Term Col – 5 mg Col – 10 mg Col
(N= 120) (N=120) (N=100)
___________________________________________________________________________
Number of Patients With
Expected Adverse Event (s) 40( 40.0%) 15(15.0%) 7(7.0%)
GROUP100 20(50.0%) 7(46.6%) 4(57.1%)
Exevent1 10(50.0%) 3(42.8%) 2(50.0%)
Exevent2 3(15.0%) 2(28.5%) 0(00.0%)
Exevent3 7(35.0%) 3(20.0%) 0(00.0%)
GROUP200 13(32.5%) 2(13.3%) 1(14.2%)
Exevent1 7(53.8%) 1(50.0%) 1(100.0%)
Exevent2 2(15.3%) 0(00.0%) 0(00.0%)
Exevent3 4(30.7%) 1(50.0%) 0(00.0%)
GROUP300 7(17.5%) 2(13.3%) 1(14.2%)
Exevent1 4(57.1%) 2(100.0%) 1(100.0%)
Exevent2 1(14.2%) 0(00.0%) 0(00.0%)
Exevent3 2(28.5%) 0(00.0%) 0(00.0%) _____________________________________________________________________________
To Caluculate Percentage NO of adevent sub / Total No of Project
No comments:
Post a Comment